B, P., AR, B., R, S., R, C., F, S., F, G., . . . I, G. (2022). Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience. Transplantation, 106(7), e343. https://doi.org/10.1097/TP.0000000000004150
Chicago Style (17th ed.) CitationB, Pinchera, et al. "Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience." Transplantation 106, no. 7 (2022): e343. https://doi.org/10.1097/TP.0000000000004150.
MLA (9th ed.) CitationB, Pinchera, et al. "Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience." Transplantation, vol. 106, no. 7, 2022, p. e343, https://doi.org/10.1097/TP.0000000000004150.